Dietary sources of nitrite as a modulator of ischemia/reperfusion injury  by Garg, Harsha K. & Bryan, Nathan S.
Dietary sources of nitrite as a modulator of
ischemia/reperfusion injury
Harsha K. Garg1 and Nathan S. Bryan1
1Brown Foundation Institute of Molecular Medicine, The University of Texas—Houston Health Sciences Center, Houston, Texas, USA
The nitrite anion is an endogenous product of nitric oxide
(NO) metabolism, a key intermediate in the nitrogen cycle in
plants and bacteria, and a constituent of many foods.
Research over the past 6 years has revealed a surprising
biological and cytoprotective activity of this anion. Its ability
to restore NO homeostasis throughout the physiological
oxygen gradient in vivo has transformed this once-thought to
be inert anion into a critical molecule in health and disease.
Ischemia–reperfusion (I/R) injury is a major clinical problem
worldwide. NO has been shown to be one of the most
important molecules for the prevention of injury from I/R.
Paradoxically, however, enzymatic NO formation from NO
synthase (NOS) is inactive during conditions of inadequate
oxygen and substrate delivery, such as in ischemia. Nitrite
has emerged as a viable alternative source of NO under
ischemic conditions. As nitrite is known to be derived not
only from the oxidation of NO but also through diet,
understanding nitrite metabolism and mechanisms of
cytoprotection may offer novel and natural means to
prevent disease or at least limit injury from an I/R event.
Here, we review the current body of knowledge regarding
dietary sources of nitrite and its modulation of cytoprotection
in an I/R injury.
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The production of nitric oxide (NO) from L-arginine is a
critical cellular function in most, if not all, organ systems
throughout the body. The inability of our body to produce
NO is the earliest indication that disease will ensue. Our
ability to produce NO from the classical L-arginine pathway is
complex and requires normal blood flow, allowing adequate
oxygen and substrate delivery to the NO synthase (NOS)
enzymes. One of the most important clinical conditions that
affect public health today is ischemia–reperfusion (I/R)
injury. I/R-induced injury and inflammation represents a
major clinical problem associated with hemorrhagic or
endotoxin shock and thermal injury, as well as transplanta-
tion and resectional surgery, stroke, heart attack, and sickle
cell disease. I/R injury is also the predominant underlying
cause of acute renal failure. Ischemia is defined as a
disruption or deficiency in blood flow either because of
vessel constriction or physical obstruction of the vessel as in
atherosclerosis. Reperfusion is the restoration of blood flow
to ischemic tissue. I/R injury remains the leading cause of
morbidity and mortality in all industrialized nations and is
an enormous economic burden in treating and caring for
patients. Developing strategies to limit the amount of injury
from an I/R insult will improve patient outcome, enhance
recovery, and lead to a better quality of life regardless of the
site or tissue of I/R injury. There are two distinct components
of damage in patients who experience an I/R event: ischemic
injury and reperfusion injury. Most tissues are able to tolerate
brief periods of ischemia, as the activation of inherent,
adaptive mechanisms can preserve energy levels and prevent
injury. These include switching metabolism to anaerobic
glycolysis and fatty acid utilization, increasing glucose
uptake, and decreasing contractility as in the case of cardiac
ischemia. However, if ischemia persists, the tissue will
develop a severe adenosine triphosphate (ATP) deficit,
resulting in an irreversible injury and culminating in cell
death. Although reperfusion of ischemic tissues provides
oxygen and metabolic substrates necessary for the recovery
and survival of reversibly injured cells, reperfusion itself
results paradoxically in the acceleration of cellular necrosis.
Reperfusion is characterized by the formation of oxygen
radicals upon re-introduction of molecular oxygen to
ischemic tissues, resulting in widespread lipid and protein
oxidative modifications, mitochondrial injury, as well as
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tissue apoptosis and necrosis. NO has been shown to be a
critical molecule in limiting an I/R injury. However, the L-
arginine–NO pathway is not functional during ischemia
because of insufficient oxygen, substrate delivery, and
reduced co-factors for the NOS enzyme.
The loss of NO generation as a result of a dysfunctional
vascular endothelium is very likely the cause of cardio-
vascular disease, which can affect all organ systems including
the renal system. A report by Kleinbongard et al.1 showed
that plasma nitrite levels decrease progressively with
increasing cardiovascular risk load. Risk factors considered
include age, hypertension, smoking, and hypercholesterole-
mia, conditions all known for the reduced bioavailability
of NO. Although a correlation exists in the plasma, it is
not known whether the situation is mirrored in tissue at risk
for ischemic injury or disease. A growing body of experi-
mental data suggests that an important initiating
event in the pathophysiology of I/R-induced tissue
injury is the decreased production of NO concomitant with
increased generation of reactive oxygen species. Therefore,
strategies designed to enhance NO production and reduce
reactive oxygen species production will likely limit injury and
improve recovery from an I/R insult. Nitrite has emerged as
an ideal candidate. As a substantial portion of steady-state
nitrite concentrations in blood and tissue are derived
from dietary sources,2 modulation of nitrite intake may
provide a first line of defense for cardiovascular disease and
also protection from an I/R injury. This review will
summarize the current state of nitrite research regarding
dietary contributions and the role played in modulating an
I/R injury.
Nitrite homeostasis
The endogenous production of NO by NOS has been
established as playing an important role in vascular
homeostasis, neurotransmission, and host defense mechan-
isms. The major pathway for NO is the stepwise oxidation
to nitrite and nitrate. In plasma, NO is oxidized almost
completely to nitrite, in which it remains stable for
several hours.3 In contrast, NO and nitrite are oxidized
rapidly to nitrate in whole blood. NO can also be oxidized
enzymatically to nitrite by cerulopasmin or other metal-
containing proteins. The half-life of nitrite in human blood
is about 110 s.3 Nitrate, on the other hand, has a circulating
half-life of 5–8 h.3 During fasting conditions with a low previ-
ous intake of nitrite/nitrate, NOS derived NO oxidation
accounts for the majority of nitrite.4 Prior to these studies, it
was thought that the steady-state levels of nitrite and nitrate
originated solely from nitrogen-fixing enteric bacteria.
In addition to the oxidation of NO, nitrite is produced by
the consumption of food, such as meat, vegetables, and
drinking water. Nitrite and nitrate have been used for
centuries in curing and preserving meats and fish and in
manufacturing certain cheeses. When added to foods, such as
cured meats, nitrite has at least three functions. First, it
contributes to the flavor because of the inhibition of the
development of rancidity. Second, it reacts with myoglobin to
produce mononitrosylhemochrome, which results in the
characteristic pink color of cured meat. Third, it inhibits the
growth of food spoilage bacteria Clostridium botulinum,
being the most important. C. botulinum thrives under
anaerobic conditions and produces a neurotoxin, which is
one of the most lethal natural products known. In this regard,
nitrite is critical to the food industry for prevention of food-
borne illness. Nitrite in meats represents a small contribution
from the diet. Most of the dietary sources of nitrite are
derived from nitrate-rich vegetables.
Nitrite can be derived from reduction of salivary nitrate
by commensal bacteria in the mouth and gastrointes-
tinal tract.5–7 About 25% of orally ingested available nitrate
is secreted actively into the saliva. This nitrate is partially
converted to nitrite by oral bacteria and then dispropor-
tionates with the formation of NO after entering the acidic
environment of the stomach, helping to reduce gastrointes-
tinal tract infection, increase mucous barrier thickness, and
increase gastric blood flow.8 Proton pump inhibitors or
chronic administration of antacids can adversely affect NO
formation from nitrite in the stomach.6 Humans, unlike
prokaryotes, are thought to lack the enzymatic machinery to
reduce nitrate back to nitrite. However, recent discoveries
reveal a functional mammalian nitrate reductase.9 Commen-
sal bacteria that reside within and on the human body
can reduce nitrate, thereby, supplying a large and alternative
source of nitrite. Therefore, dietary and enzymatic sources of
nitrate are a potentially large source of nitrite in the
human body. The concentrations of nitrate in drinking
water are usually o10 mg/l in the absence of bacterial
contamination. Vegetables, especially beets, celery, and leafy
vegetables like lettuce and spinach are rich in nitrates. Other
vegetables contain nitrate at lower concentrations, but
because they are consumed in greater quantity, they may
contribute more nitrate and thus nitrite from the diet.
For the average population, most nitrate exposure (86%)
comes from vegetables, whereas the primary contributors to
nitrite intake are cured meats (39%), baked goods and
cereals (34%), and vegetables (16%). The National Research
Council report, The Health Effects of Nitrate, Nitrite, and
N-Nitroso Compounds (NRC 1981), reported estimates of
nitrite and nitrate intake based on food consumption
tables. They report that the average total nitrite and
nitrate intake in the United States was 0.77 and 76 mg,
respectively per day. In a recent study, comparing a daily
menu composed of what resembles a western- and a
Mediterranean-style diet, we find that the latter contains a
considerably higher amount of nitrite, nitrate, and poly-
phenolic antioxidants.10 Traditional dietary habits of the
Mediterranean area have been associated consistently with
a lower incidence of cardiovascular disease and cancer.
By contrast, consumption of the western-style diet increases
incidence of disease. Is the difference in nitrite and nitrate
intake responsible for the stark differences in region-specific
disease epidemiology?
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Dietary nitrite and nitrate contribute to endogenous NO
biochemistry
Several studies now show that exogenous nitrite contributes
to whole-body NO production and homeostasis, and is an
alternate source of NO in vivo. Co-administration of nitrite
with a NOS inhibitor for 3 weeks significantly attenuates
hypertension11 and improves renal injury induced by the
chronic L-NG-nitro-arginine methyl ester treatment.12 Inter-
esting, however, are the divergent published results of nitrite
in kidney I/R insults. Tripatara et al.13 reveal that nitrite
protects the kidney from 60-min ischemia after 6-h
reperfusion, when administered topically as determined by
a reduction in serum creatinine and aspartate aminotrans-
ferase. However, results from Basireddy et al.14 report that
intraperitoneal or intravenous administration of nitrite
provides no protection from 45-min ischemia after 24 and
48 h of reperfusion in the kidney, when administered
intravenously 45 min prior to ischemia or intraperitoneally
either before or during ischemia. Blood urea nitrogen and
serum creatinine were used as indices of injury. This
discrepancy may be because of a number of factors, including
route of administration, time of administration in reference
to the ischemic insult, and/or time of reperfusion upon
which the injury was measured. Although the Tripatara study
assesses the acute protective effects of nitrite after 6 h,
Basireddy et al. assess their first time point after 24 h. It may
be that the protective effects seen by Tripitara are simply
‘cosmetic’ and markers of injury are delayed and reveal no
protection after 24 or 48 h. Only a comprehensive time
course with a common route of administration will deter-
mine such effects. The pharmacokinetics and pharmacody-
namics of nitrite is dictated by its route of administration, the
concentration of the stock solution administered, and the
period of infusion relative to time of ischemia. These are all
critical considerations that are often under-appreciated.
Nitrate also contributes to the NO status of mammals
with the participation of commensal bacteria. Lundberg and
Govoni15 showed that plasma nitrite increases after consum-
ing nitrate. Both nitrite and nitrate are common constituents
of our diet. There are now several studies exploring the use of
dietary nitrite and nitrate manipulations on endogenous NO
biochemistry and changes in physiological outcome from
an I/R injury.16,17 The recent report by Webb et al.18 shows
that dietary nitrate through its reduction to nitrite can
lower blood pressure, prevent I/R-mediated endothelial
dysfunction, and attenuate platelet aggregation in humans.
Collectively, these studies reveal clearly the benefits of nitrite
and nitrate from the diet as a means to restore or enhance
NO bioavailability and/or homeostasis.
Nitrite administered in drinking water affects steady-state
concentrations of NO products/metabolites
Recent investigations17 reveal that dietary nitrite insuffi-
ciency, through feeding a low-NOx diet, results in diminished
circulating and tissue steady-state nitrite and nitrate
concentrations in mice. On the contrary, supplementation
with 50-mg/l nitrite in drinking water restores nitrite status
in mice fed the low-NOx diet, and actually increases the
nitrite concentrations in mice fed standard rodent chow.
High doses of nitrite ingestion are associated with reducing
hypertension in rats,11 and dietary nitrate has been shown to
lower blood pressure in humans.19 These data reveal that
changes in dietary nitrite and nitrate consumption can affect
the steady-state concentrations of blood and tissue NO
products/metabolites commonly used to assess NO produc-
tion and, therefore, contribute to NO homeostasis.
Nitrite insufficiency leads to increased I/R injury in healthy
mice, which is reversed by nitrite supplementation
in drinking water
Modulating dietary nitrite through dietary restriction was
shown to deplete blood and tissue of nitrite and affect
myocardial I/R injury.2,17 Bryan et al.17 reveal that a decrease
in nitrite bioavailability through dietary nitrite insufficiency
exacerbates myocardial injury. Infarct size, as measured by
infarct size relative to area-at-risk, was found to increase by
36% in mice fed the low-NOx diet as compared with that in
control mice. Mice fed the low-NOx diet also had a higher
mortality rate post myocardial infarction than mice on the
standard rodent chow (56.5% survival vs 71.4% survival).
Repleting nitrite through supplementing drinking water
reversed the increased myocardial infarct size incurred by
nitrite insufficiency and resulted in an increased survival back
to control levels. These data show unequivocally physiologi-
cal changes in outcome based on changes in dietary nitrite
intake and resultant changes in blood and tissue nitrite. As
the steady-state concentrations of blood and tissue nitrite are
affected by dietary changes in NOx, and these changes
translate into a change in recovery from I/R, diet must play a
critical role in the NO signaling pathway and cardiovascular
health. Could modest changes in dietary habits to increase
nitrite and nitrate ingestion affect outcome in humans
suffering from ischemic events or decrease the incidence for
people at risk?
Dietary nitrite insufficiency unmasks NO biochemistry in
eNOS/ mice and supplementation restores NO
biochemistry
Enzymatic NO insufficiency is a hallmark of a number of
diseases. A recent study by Bryan et al.16 reveals that dietary
nitrite supplementation can restore NO and nitrite status in
the eNOS knockout mice and protect from myocardial I/R
injury. Our data reveal the eNOS/ mice have lower plasma
nitrite concentrations, but there is no significant difference in
cardiac nitrite revealing that blood markers do not accurately
reflect tissue status. Plasma nitrite could be further decreased
by feeding the eNOS/ mice a low-NOx diet showing that
plasma nitrite is a reflection of both NOS activity and diet.
Feeding a low-NOx diet to the eNOS/ mice completely
eliminated the steady-state concentrations of plasma nitro-
sothiols without any effect on cardiac levels. Supplementation
of 50-mg/l nitrite in drinking water for 7 days restored
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plasma nitrite in the eNOS/ to control levels and increased
both plasma and cardiac nitrosothiols. These data are
important because they indicate proof of principle that
exogenous dietary nitrite can restore NO biochemistry under
conditions of dysfunctional NOS. Furthermore, supplemen-
tal nitrite can restore NO–nitroso redox balance in the eNOS
knockout mice and, therefore, provide justification for
studies on nitrite therapy in humans with diseases associated
with NO insufficiency with the potential of exogenous nitrite
to restore NO homeostasis.
Mechanisms of protection
We have earlier shown that nitrite can form nitrosothiols in a
first-order reaction requiring heme and thiols and can also be
reduced to NO under anaerobic conditions.2 As both NO and
nitrosothiols (RSNOs) have now been shown to be protective
in the setting of I/R, nitrite now becomes the central
molecule in that it can form both NO and RSNOs. We
propose that nitrite serves two functions in the setting of
ischemia and reperfusion. First, it may serve as a NOS-
independent source of NO by which nitrite may be reduced
to NO in the local ischemic microenvironment when NOS is
inactive. Second, nitrite reacts with critical thiols to form
nitrosothiols under normoxic conditions and this conversion
is more pronounced during ischemia.2,17 Shiva et al.20 has
shown specific nitrosylation of complex I during I/R. They
suggest a mechanism of protection, in which nitrosylation
inhibits complex I dampening electron transfer, effectively
reducing reactive oxygen species generation during reperfu-
sion and ameliorating oxidative inactivation of complexes
II–IV and aconitase, thus, preventing mitochondrial perme-
ability transition pore opening, and cytochrome c release.
This nitrosylation event can act as a reversible protective
shield, which prevents the irreversible oxidation of proteins
and lipids during the oxidative burst of reperfusion or simply
elicit specific cell signaling that confers a protective
phenotype. Aside from ‘capping’ critical thiols from oxida-
tion, we propose that nitrosothiols can then be reduced to
release NO or the NOþ moiety during the reperfusion phase
and act as a redox-sensitive NO donor. Our biochemical data
support this notion in terms of the increase in nitrosothiols
at the expense of nitrite followed by the decay of nitrosothiols
over time during reperfusion.17 Therefore, adding supple-
mental nitrite increases plasma and tissue nitrite also leading
to an increase in the steady-state levels of nitrosothiols and,
thereby, affording protection during I/R. Nitrite, then acts as
a central molecule in I/R by its ability to protect against both
ischemic injury and reperfusion injury. On the contrary,
nitrite insufficiency leads to increased injury because there is
insufficient nitrite or nitrosothiols stored in blood or tissue
to carry out these protective actions. This viewpoint is
illustrated in Figure 1.
Summary
There are now numerous reports on the therapeutic benefits
of nitrite in an I/R injury. However, most studies administer
exogenous nitrite during ischemia or prior to reperfusion.
Owing to the relatively short circulating half-life of nitrite,
the therapeutic window of opportunity is very narrow and,
thus, the opportunity to intervene is limited. A more logical
approach may be to enhance the dietary consumption of
nitrite and nitrate as a prophylaxis for people at risk for I/R
injury. Given that nitrates/nitrites are cleared in the kidney,
the clearance rate and, therefore, the steady-state circulating
levels may vary considerably based on renal function. There
may be limitations of dietary nitrite therapy for particular
cases, such as diabetes or metabolic syndrome patients, or
patients with chronic renal disease. Numerous epidemiolo-
gical data have indicated an inverse relationship between
dietary intake of fruits and vegetables and incidence of
cardiovascular disease. An optimal diet may then consist of a
sufficient supply of nitrite and nitrate for health and
protection from an I/R injury. Regular intake of nitrite-
and nitrate-containing foods may ensure that blood and
tissue levels of nitrite and nitrosothiols are maintained at a
level sufficient to compensate for any disturbances in
endogenous NO synthesis and provide a sufficient NO buffer
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Figure 1 | Diet and endothelium-redundant systems for NO
homeostasis. (a) Plasma nitrite is derived from dietary nitrite and
nitrate and also from oxidation of endogenous nitric oxide.
Tissues maintain a tight steady-state concentration of nitrite
despite wide fluctuations in plasma nitrite. Therefore, plasma
nitrite may not always accurately reflect tissue concentrations.
Plasma can act as a reservoir for tissue nitrite to draw upon in
times of need, as long as there is a sufficient buffer of plasma
nitrite available. (b-upper) There is a concerted effort through
dietary NOx and NOS to maintain both nitrite and NO
bioavailability and, thus, steady-state tissue nitroso/nitrosyl. One
may compensate for the other provided both pathways are active
with ample substrate. (lower) When dietary intake of NOx is
limited, combined with a dysfunctional NOS, there is no source of
nitrite or NO and, as a result, there is altered signaling and protein
expression, which may lead to the progression of disease. (c)
Supplemental nitrite can increase plasma and tissue nitrite/RSNO,
thereby, providing an alternative source of NO when NOS is
inactive (during ischemia). Conversely, inadequate nitrite leads to
decreased steady-state NO and exacerbated injury from I/R.
Therefore, it is critical to maintain NO and NOx homeostasis for
optimal health.
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during ischemia. As the low levels of nitrite and nitrosothiols
have been shown to enhance blood flow, dietary sources of
NO metabolites could therefore improve circulation and
oxygen delivery. This dietary pathway may not only provide
essential nutrients for NO production but also provides a
rescue or protective pathway for people at risk for an I/R
injury.
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